Evidence map›Paper›PMID 41206241›Full record

ArticleEBioMedicine2025

Treatment in acute HIV infection only temporarily preserves monocyte function: a comparative cohort study in adult males.

Killian E Vlaming, Pien M van Paassen, John L van Hamme, Stella Schonherr, Tanja M Kaptein, Karel van Dort, Irma Maurer, Reinout van Crevel, Casper Rokx, Liffert Vogt and 5 more

Abstract readComparative Study
In one paragraph

Article in EBioMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Killian E VlamingAmsterdam UMC Location University of Amsterdam, Department of Experimental Immunology, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Institute for Infectious Diseases and Immunology, Amsterdam, the Netherlands.
Pien M van PaassenAmsterdam UMC Location University of Amsterdam, Department of Experimental Immunology, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Institute for Infectious Diseases and Immunology, Amsterdam, the Netherlands.
John L van HammeAmsterdam UMC Location University of Amsterdam, Department of Experimental Immunology, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Institute for Infectious Diseases and Immunology, Amsterdam, the Netherlands.
Stella SchonherrAmsterdam UMC Location University of Amsterdam, Department of Experimental Immunology, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Institute for Infectious Diseases and Immunology, Amsterdam, the Netherlands.
Tanja M KapteinAmsterdam UMC Location University of Amsterdam, Department of Experimental Immunology, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Institute for Infectious Diseases and Immunology, Amsterdam, the Netherlands.
Karel van DortAmsterdam UMC Location University of Amsterdam, Department of Experimental Immunology, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Institute for Infectious Diseases and Immunology, Amsterdam, the Netherlands.
Irma MaurerAmsterdam UMC Location University of Amsterdam, Department of Experimental Immunology, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Institute for Infectious Diseases and Immunology, Amsterdam, the Netherlands.
Reinout van CrevelDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, the Netherlands.
Casper RokxDepartment of Internal Medicine and Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands.
Liffert VogtApheresis Unit, Dianet, Location Amsterdam UMC, Amsterdam, the Netherlands.
Jan M PrinsDepartment of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC, Amsterdam, the Netherlands.
Neeltje A KootstraAmsterdam UMC Location University of Amsterdam, Department of Experimental Immunology, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Institute for Infectious Diseases and Immunology, Amsterdam, the Netherlands.
Teunis B GeijtenbeekAmsterdam UMC Location University of Amsterdam, Department of Experimental Immunology, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Institute for Infectious Diseases and Immunology, Amsterdam, the Netherlands. Electronic address: T.B.Geijtenbeek@amsterdamumc.nl.
Godelieve J de BreeDepartment of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC, Amsterdam, the Netherlands.
NOVA study team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPersistent monocyte activation and altered cytokine responses are reported in PWH despite ART. How prior HIV-1 infection status and timing of ART initiation relate to monocyte pattern-recognition receptor crosstalk between TLR8 and RLRs remains uncertain.

methodsWe conducted a comparative cohort study in adult males enrolled from two Dutch HIV-cohorts. Participants included HIV-negative participants, PWH who initiated ART during chronic HIV infection, and PWH who initiated ART during acute HIV infection, with sampling at 24 and 156 weeks after ART initiation for the acute group. PBMCs were stimulated with an RLR agonist, a TLR8 agonist, or both. Monocyte surface markers were assessed by flow cytometry and pro-inflammatory cytokines were analysed with qPCR and ELISA.

findingsAcross groups, RLR stimulation induced IL-12p70 and IL-27, TLR8 stimulation induced IL-6 and IL-12p70 and combined TLR8 + RLR co-stimulation synergistically increased IL-12p70 and IL-27 while restricting IL-6. Compared with controls, CHI showed reduced IL-12p70 and IL-27 and higher IL-6. In AHI at 24 weeks, cytokine patterns and co-stimulation effects resembled HIV-negative participants; by 156 weeks, responses were attenuated and approximated CHI.

interpretationIn this male cohort, TLR8-RLR crosstalk was preserved early after ART initiation during acute infection but diminished over time, approaching profiles observed in chronically treated infection. These observations emphasise a potential early window after ART initiation for interventions aiming to preserve monocyte function and motivate studies to characterise underlying mechanisms.

fundingFunding for this study was obtained through a ZonMW/Aidsfonds grant NL4Cure: Bridging shock and kill strategies (446002508).

Indexed as

HIV InfectionsMonocytesAcute DiseaseAdultBiomarkersCohort StudiesCytokinesHIV-1HumansMaleMiddle AgedToll-Like Receptor 8BiomarkersCytokinesTLR8 protein, humanToll-Like Receptor 8HIV-1Innate immunityMonocytesRIG-I like receptorsToll like receptor 8

Identifiers

PMID41206241
PMCPMC12790590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.